CardioVascular BioTherapeutics (fka CVBT)

[hapcody]

The biggest limit or danger to this investment is any government run healthcare or control / limits / price controls on drug companies. The new managment has a plan and motive to gain value for the stock. Time is not on our side. It will be two more years (just a guess) before this stock can relist. If they do so before completion of trials and getting products , medicines marketable, the stock price is too low and raising money not possible. That magic $3 number that has been tossed around means the company is a $1 billion dollar valuation ( 300plus million shares). Does anyone belive this company can turn a profit? Much less be worth a billion?
Maybe but not likely. Give it 2 years and some pattents and products and a way to make profit and that $3 share price has a chance.
I liked what was said at the meeting , this company is an incubator. I like that idea. Its not about one discovery but being a place to advance discovery for medicines and procedures.
Just my thoughts. I have no knowledge of the medical field, drug companies or investing. Just what little I have picked up on my investment (100k shares). Praying it becomes a relisted company that provides value, thus is of value.